Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

Week in Review: How statin use benefits COVID-19 patients | Cannabis & CV health | Lessons from the pandemic

News You Need to Know Today
Week in Review: How statin use benefits COVID-19 patients | Cannabis & CV health | Lessons from the pandemic
Saturday, August 15, 2020
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

This Week’s News

Top Stories

Statin use lowers the risk of severe illness from COVID-19 by 30%

Some researchers have shared concerns about how statin use may impact COVID-19 patients, but a new meta-analysis suggests there is a significant benefit. 

READ MORE >
covid.jpg
Share on Twitter Share on Facebook Share on Linkedin

Statin use lowers the risk of severe illness from COVID-19 by 30%

Share on Twitter Share on Facebook Share on Linkedin
covid.jpg
Some researchers have shared concerns about how statin use may impact COVID-19 patients, but a new meta-analysis suggests there is a significant benefit. 
READ MORE >

5 key takeaways from a new study on cannabis and cardiovascular health

Medicinal marijuana has gained considerable acceptance in recent years, and some states have even legalized the recreational use of the drug. But what are its impacts on a person’s cardiovascular health?

READ MORE >
weed-2517251_960_720.jpg
Share on Twitter Share on Facebook Share on Linkedin

5 key takeaways from a new study on cannabis and cardiovascular health

Share on Twitter Share on Facebook Share on Linkedin
weed-2517251_960_720.jpg
Medicinal marijuana has gained considerable acceptance in recent years, and some states have even legalized the recreational use of the drug. But what are its impacts on a person’s cardiovascular health?
READ MORE >

Lessons learned: Cardiovascular specialists share 4 key takeaways from the pandemic

COVID-19 disrupted nearly every aspect of the U.S. healthcare system, but it also helped providers examine patient care from a new perspective and ask some big questions.

READ MORE >
Covid Fight
Share on Twitter Share on Facebook Share on Linkedin

Lessons learned: Cardiovascular specialists share 4 key takeaways from the pandemic

Share on Twitter Share on Facebook Share on Linkedin
Covid Fight
COVID-19 disrupted nearly every aspect of the U.S. healthcare system, but it also helped providers examine patient care from a new perspective and ask some big questions.
READ MORE >

American Heart Association retracts, denounces anti-affirmative action article after heavy backlash

One of the article’s biggest critics, it seems, was the author’s own institution.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

American Heart Association retracts, denounces anti-affirmative action article after heavy backlash

Share on Twitter Share on Facebook Share on Linkedin
One of the article’s biggest critics, it seems, was the author’s own institution.
READ MORE >

Featured Articles

Pupil measurements predict all-cause mortality among heart failure patients

The study's authors explored data from 870 acute heart failure patients treated at the same facility from January 2012 to December 2017.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Pupil measurements predict all-cause mortality among heart failure patients

Share on Twitter Share on Facebook Share on Linkedin
The study's authors explored data from 870 acute heart failure patients treated at the same facility from January 2012 to December 2017.
READ MORE >

Atrial fibrillation outcomes have improved, but more work is still necessary to ‘stem the epidemic’

Researchers explored 43 years of data from the Framingham Heart Study.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Atrial fibrillation outcomes have improved, but more work is still necessary to ‘stem the epidemic’

Share on Twitter Share on Facebook Share on Linkedin
Researchers explored 43 years of data from the Framingham Heart Study.
READ MORE >

Policy update: CMS proposes expanded coverage for artificial hearts, LVADs

The proposed changes, announced August 12, are focused on easing a variety of requirements.

READ MORE >
Large peridevice leaks after left atrial appendage occlusion (LAAO) are incredibly rare and not associated with a greater risk of adverse outcomes, according to new research published in JACC: Clinical Electrophysiology.[1] Smaller residual links are more common, however, and associated with a risk of thromboembolic and bleeding events.
Share on Twitter Share on Facebook Share on Linkedin

Policy update: CMS proposes expanded coverage for artificial hearts, LVADs

Share on Twitter Share on Facebook Share on Linkedin
Large peridevice leaks after left atrial appendage occlusion (LAAO) are incredibly rare and not associated with a greater risk of adverse outcomes, according to new research published in JACC: Clinical Electrophysiology.[1] Smaller residual links are more common, however, and associated with a risk of thromboembolic and bleeding events.
The proposed changes, announced August 12, are focused on easing a variety of requirements.
READ MORE >

In-hospital bleeding, 30-day mortality higher among women undergoing TAVI

The study tracked nearly 700 patients who underwent TAVI at one of two facilities in Melbourne, Australia, over a ten-year period. 

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

In-hospital bleeding, 30-day mortality higher among women undergoing TAVI

Share on Twitter Share on Facebook Share on Linkedin
The study tracked nearly 700 patients who underwent TAVI at one of two facilities in Melbourne, Australia, over a ten-year period. 
READ MORE >

Big Ten, Pac-12 cancel 2020 season due to concerns over COVID-19, myocarditis

At this rate, will there be a 2020 college football season at all?

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Big Ten, Pac-12 cancel 2020 season due to concerns over COVID-19, myocarditis

Share on Twitter Share on Facebook Share on Linkedin
At this rate, will there be a 2020 college football season at all?
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

OIG questions vascular procedures | Things to consider before signing your next contract | Is coffee bad for the heart?
Looking Back: Cardiovascular care hit by major recalls | New payment model on the way | SMART update | Trends in cardiac CT
Another Impella warning | Devices stolen, sold to patients | FDA impressed by new AI software | SAPT after TAVR
Week in Review: FDA confirms recall for vascular device | BATMAN to the rescue | Prasugrel after PCI | GLP-1 drugs & AFib
News Alert: FDA shares new warning about Impella heart pumps after death
AHA takes on cardiac amyloidosis | Have clinicians been wrong about PAD? | FDA OKs new AI for heart failure
Insulin pods recalled | Cardiology groups support bill | Treating ‘broken hearts’ | AI delivers answers | Prasugrel after PCI

Pagination

    • First page « First
    • Previous page ‹‹
    • Page 1
    • Current page 2
    • Page 3
    • Page 4
    • Page 5
    • Page 6
    • Page 7
    • Page 8
    • Page 9 …
    • Next page ››
    • Last page Last »
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme